Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,888
datasets available to search
ShareScore release 0.9.0
Dataset results
2,888 results for “Alzheimer's disease”
Imaging Inflammation in Alzheimer's Disease
ClinicalTrials.gov study NCT02831283. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
ClinicalTrials.gov study NCT05562583. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
ClinicalTrials.gov study NCT01584440. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of BHV-4157 in Alzheimer's Disease
ClinicalTrials.gov study NCT03605667. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia
ClinicalTrials.gov study NCT03422250. IPD Sharing: NO. Countries: 1. Publications: 2.
Monetary Cost of Alzheimer's Disease in China
ClinicalTrials.gov study NCT02694445. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00479557. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients
ClinicalTrials.gov study NCT00996918. IPD Sharing: Not stated. Countries: 17. Publications: 1.
An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum
ClinicalTrials.gov study NCT02406027. IPD Sharing: Not stated. Countries: 6. Publications: 1.
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
ClinicalTrials.gov study NCT02337907. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00348309. IPD Sharing: YES. Countries: 19. Publications: 1.
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
ClinicalTrials.gov study NCT03507790. IPD Sharing: NO. Countries: 5. Publications: 1.
Senolytic Therapy to Modulate Progression of Alzheimer's Disease
ClinicalTrials.gov study NCT04063124. IPD Sharing: YES. Countries: 1. Publications: 7.
Resveratrol for Alzheimer's Disease
ClinicalTrials.gov study NCT01504854. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's
ClinicalTrials.gov study NCT06424236. IPD Sharing: YES. Countries: 6. Publications: 13.
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
ClinicalTrials.gov study NCT00818662. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov study NCT00478205. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT04491006. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
ClinicalTrials.gov study NCT05738486. IPD Sharing: YES. Countries: 2. Publications: 1.
Study on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimer's Disease
ClinicalTrials.gov study NCT04509271. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.